Home/Filings/4/0000921895-20-002310
4//SEC Filing

O'Connor Rita M 4

Accession 0000921895-20-002310

CIK 0001497504other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 9:12 AM ET

Size

7.0 KB

Accession

0000921895-20-002310

Insider Transaction Report

Form 4
Period: 2020-08-20
O'Connor Rita M
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-08-20$3.77/sh+2,300$8,6662,300 total
  • Purchase

    Common Stock

    2020-08-21$3.97/sh+4,050$16,0916,350 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.74 to $3.80, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.85 to $4.10, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.

Issuer

PLx Pharma Inc.

CIK 0001497504

Entity typeother

Related Parties

1
  • filerCIK 0001389177

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 9:12 AM ET
Size
7.0 KB